New Drug's journey through the body tracked in small study
NCT ID NCT07537231
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looks at how healthy postmenopausal women absorb, break down, and eliminate the experimental drug GS1-144. Six participants will take a single oral dose, and researchers will measure the drug and its byproducts in blood, urine, and stool. The goal is purely to understand the drug's behavior in the body, not to treat any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABSORPTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Suzhou, 214062, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart hormone boost may cut diabetes risk in black individuals — a trial puts it to the test
- Plant protein processing: friend or foe to your gut?
- Veterans study: shedding pounds and moving more may cool inflammation
- When you eat matters: study reveals meal Timing's impact on metabolism
- Gut check: where you absorb fatty acids matters
- Gut bacteria byproducts may control Appetite—Study tests where they work best